Ibrutinib versus placebo in patients with asymptomatic, treatment-naive early stage chronic lymphocytic leukemia (CLL): primary endpoint results of the phase 3 double-blind randomized CLL12 trialPetra Langerbeins,Jasmin Bahlo, Christina Rhein, Henrik Gerwin,Paula Cramer,Moritz Fuerstenau,Othman Al-Sawaf,Julia von Tresckow,Anna-Maria Fink,Karl-Anton Kreuzer,Ursula Vehling-Kaiser,Eugen Tausch, Lothar Mueller,Michael J. Eckart,Rudolf Schlag,Werner Freier,Tobias Gaska,Christina Balser,Marcel Reiser,Martina Stauch,Clemens Martin Wendtner,Marcel Reiser,Martina Stauch,Kirsten Fischer,Stephan Stilgenbauer,Barbara Eichhorst,Michael HallekLEUKEMIA & LYMPHOMA(2020)引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要